These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25806962)

  • 1. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
    Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
    Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.
    Morais S; Oliveira J; Lau C; Pereira M; Gonçalves M; Monteiro C; Gonçalves AR; Matos R; Sampaio M; Cruz E; Freitas I; Santos R; Lima M
    PLoS One; 2020; 15(12):e0235136. PubMed ID: 33276370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.
    Bury L; Falcinelli E; Chiasserini D; Springer TA; Italiano JE; Gresele P
    Haematologica; 2016 Jan; 101(1):46-56. PubMed ID: 26452979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
    Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
    Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
    González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
    Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
    Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
    Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
    Pillois X; Peters P; Segers K; Nurden AT
    Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
    Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
    Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia.
    Kunishima S; Kashiwagi H; Otsu M; Takayama N; Eto K; Onodera M; Miyajima Y; Takamatsu Y; Suzumiya J; Matsubara K; Tomiyama Y; Saito H
    Blood; 2011 May; 117(20):5479-84. PubMed ID: 21454453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3).
    Peretz H; Rosenberg N; Landau M; Usher S; Nelson EJ; Mor-Cohen R; French DL; Mitchell BW; Nair SC; Chandy M; Coller BS; Srivastava A; Seligsohn U
    Hum Mutat; 2006 Apr; 27(4):359-69. PubMed ID: 16463284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
    Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
    Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.
    Ghevaert C; Salsmann A; Watkins NA; Schaffner-Reckinger E; Rankin A; Garner SF; Stephens J; Smith GA; Debili N; Vainchenker W; de Groot PG; Huntington JA; Laffan M; Kieffer N; Ouwehand WH
    Blood; 2008 Apr; 111(7):3407-14. PubMed ID: 18065693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.
    Buitrago L; Rendon A; Liang Y; Simeoni I; Negri A; ; Filizola M; Ouwehand WH; Coller BS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1898-907. PubMed ID: 25827233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains.
    Koker MY; Sarper N; Albayrak C; Zulfikar B; Zengin E; Saraymen B; Albayrak D; Koc B; Avcilar H; Karakükcü M; Chenet C; Bianchi F; de Brevern AG; Petermann R; Jallu V
    Platelets; 2022 May; 33(4):551-561. PubMed ID: 34275420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
    Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
    Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
    Hauschner H; Mor-Cohen R; Seligsohn U; Rosenberg N
    J Thromb Haemost; 2012 Feb; 10(2):289-97. PubMed ID: 22136613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.